LAUREN SOUTH: Open Payments
NPI 1649904251 · SARATOGA SPRINGS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 80 payments from 19 companies in 2025. Trend: 2023 $673 · 2024 $1,232 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $484 |
| GlaxoSmithKline, LLC. | 8 | $132 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Novo Nordisk Inc | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $103 |
| PFIZER INC. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Lilly USA, LLC | 4 | $79 |
| Lundbeck LLC | 2 | $59 |
| Astellas Pharma US Inc | 2 | $55 |
Products named: VRAYLAR, REXULTI, TRELEGY ELLIPTA, UBRELVY, AIRSUPRA, CAPLYTA, NURTEC ODT, QULIPTA.
Industry payments across NY — which companies pay providers there.
